Literature DB >> 32159237

From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.

Mahmoud Kandeel1,2, Abdelazim Ibrahim3,4, Mahmoud Fayez5,6, Mohammed Al-Nazawi1.   

Abstract

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging disease with fatal outcomes. In this study, a fundamental knowledge gap question is to be resolved by evaluating the differences in biological and pathogenic aspects of SARS-CoV-2 and the changes in SARS-CoV-2 in comparison with the two prior major COV epidemics, SARS and Middle East respiratory syndrome (MERS) coronaviruses.
METHODS: The genome composition, nucleotide analysis, codon usage indices, relative synonymous codons usage, and effective number of codons (ENc) were analyzed in the four structural genes; Spike (S), Envelope (E), membrane (M), and Nucleocapsid (N) genes, and two of the most important nonstructural genes comprising RNA-dependent RNA polymerase and main protease (Mpro) of SARS-CoV-2, Beta-CoV from pangolins, bat SARS, MERS, and SARS CoVs.
RESULTS: SARS-CoV-2 prefers pyrimidine rich codons to purines. Most high-frequency codons were ending with A or T, while the low frequency and rare codons were ending with G or C. SARS-CoV-2 structural proteins showed 5 to 20 lower ENc values, compared with SARS, bat SARS, and MERS CoVs. This implies higher codon bias and higher gene expression efficiency of SARS-CoV-2 structural proteins. SARS-CoV-2 encoded the highest number of over-biased and negatively biased codons. Pangolin Beta-CoV showed little differences with SARS-CoV-2 ENc values, compared with SARS, bat SARS, and MERS CoV.
CONCLUSION: Extreme bias and lower ENc values of SARS-CoV-2, especially in Spike, Envelope, and Mpro genes, are suggestive for higher gene expression efficiency, compared with SARS, bat SARS, and MERS CoVs.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  COVID-19; MERS CoV; SARS-CoV-2; codon bias; nonstructural protein; preferred codons

Mesh:

Substances:

Year:  2020        PMID: 32159237      PMCID: PMC7228358          DOI: 10.1002/jmv.25754

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


INTRODUCTION

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a new emerging fatal disease emerged in Wuhan, China in December 2019. , This is the third CoV epidemic after SARS and Middle East respiratory syndrome (MERS) CoV outbreaks. Initial phylogenetic analysis indicates the formation of a common cluster with bat SARS‐like CoV isolated in 2015. Structural studies showed the close relation of the receptor‐binding domain of SARS‐CoV‐2 with SARS CoV. Three major CoV epidemics were evolved during the past few decades. The first epidemic was SARS CoV in 2003. Evidence was provided that SARS CoV was raised from an animal source including an intermediate host animal, which transmitted the virus from a bat carrier to humans. About a decade later, MERS CoV was first identified in the Arabian Peninsula. Lastly, in December 2019, the third epidemic emerged in Wuhan, China. CoVs are enveloped, positive‐stranded RNA viruses possessing a comparatively large genome approaching 30 kb and comprising four structural proteins, namely, spike (S), nucleocapsid (N) envelope (E), and membrane (M). The S protein is responsible for virus attachment to the receptor and fusion with cell membrane. , The N protein interacts with the viral RNA to form the ribonucleoprotein. The E protein helps in virions assembly and comprises ion channel actions ; the M protein shares in the assembly of new virus particles. CoV genome is organized in 10 open‐reading frames (ORFs). The 5′ encodes ORF1a and ORF1b, which are translated to give large polyproteins 1a and 1b (polyprotein AB in MERS CoV), which encodes a set of nonstructural protein. The CoV polyprotein is processed by the main protease and papain‐like protease to yield the nonstructural proteins. Analysis of genome structure and composition is a part of studies of understanding virus evolution and adaptation to host. , Some amino acids are encoded by one codon, while others are encoded by several alternative codons knows as synonymous codons. Codon bias means a preference for one codon over another during protein translation and affects translation efficiency, which differs from one organism to another. , In this study, the newly emerged fatal SARS‐CoV‐2, the four structural genes, and two most important nonstructural genes were evaluated for their nucleotide composition, preferred codons, relative synonymous codons usage (RSCU), and positively and negatively biased codons. This investigation will cover a knowledge gap in our understanding of mechanisms of viral genome evolution, the underlying codon composition, and codon usage preferences in comparison with the most recent CoV epidemic viral infections. The structural genes comprises the S, E, M, and N genes, while the nonstructural genes include the RNA‐dependent RNA polymerase (RdRP) and main protease (Mpro) genes.

MATERIALS AND METHODS

Gene data collection and analytical programs

SARS‐CoV‐2 and Pangolins Beta‐CoV complete genomes sequences were downloaded either from the NCBI GenBank or GISAID (https://www.gisaid.org/). The sequences of SARS CoV, bat SARS CoV, MERS CoV were retrieved from the gene databases at NCBI. The CLC Genomics Workbench 12.0 (QIAGEN, Aarhus, Denmark) was used to handle the sequences. The patterns of codon usage were assessed using CodonW 1.4.2.

Nucleotide composition and codon usage parameters

The nucleotide composition of the four structure genes, S, E, M, and N, were analyzed to reveal the nucleotides (A, T, G, and C) percentages. A/T, G/C percentage, the percentage of G or C nucleotides at the first position of codons (GC1), the percentage of each nucleotide at the third position of codons, the percentage of G or C nucleotides at the third position of codons (GC3) were calculated.

Relative synonymous codons usage

RSCU is calculated by dividing the expected frequencies of synonymous codon against their observed frequencies, according to Equation (1) : where X implies the observed number of codons used and ni stands for the sum of synonymous codons. The raw data for RSCU are provided in the Supporting Information Material.

The effective number of codons

ENc values range from 20 to 61. The obtained ENc value can be used to conclude the codon usage bias. An ENc value of <35 indicates strong codon usage bias due to lower number of codons used in protein translation. Higher ENc value indicates low codon usage bias. The raw data for ENc are provided in the Supporting Information Material.

RESULTS

Nucleotide compositions of the non structural proteins of SARS‐CoV‐2, SARS CoV, bat CoV, and MERS CoV

In S gene, T nucleotides were the most predominant (32%‐34%) followed by A (25%‐29%). SARS‐CoV‐2 showed the lowest GC% (37%) and the highest AT% (63%), compared with bat SARS, MERS, and SARS CoV. In addition, SARS‐CoV‐2 has the lowest percentage of G/C nucleotides at the third position of codons followed by pangolins Beta‐CoV, which showed the highest A3s. In all of the examined CoVs, the nucleotide percentages in the S gene were in the following order: T>A>C>G. In NT3s, the T3s and G3s were the most and the least frequent nucleotides, respectively (Table 1).
Table 1

The codon usage indices of S, E, M, and N genes SARS‐CoV‐2, pangolins Beta‐CoV, SARS CoV, Bat CoV, and MERS CoV

VirusT3sC3sA3sG3sNcGC3sGCGravyAromo
SpikeSARS‐CoV‐20.550.190.380.13440.250.37−0.080.11
Beta‐CoV pangolin0.510.210.400.13450.270.38−0.040.11
SARS CoV0.540.220.340.15460.290.39−0.050.12
Bat SARS CoV0.520.230.340.15480.300.39−0.050.11
MERS CoV0.530.230.280.19480.330.410.050.11
EnvelopeSARS‐CoV‐20.490.200.270.21420.340.391.130.12
Beta‐CoV pangolin0.450.230.280.21460.370.391.130.12
SARS CoV0.390.240.330.21610.380.411.140.11
Bat SARS CoV0.430.230.300.21530.360.401.150.11
MERS CoV0.380.240.440.18530.340.400.780.14
MembraneSARS‐CoV‐20.420.260.320.17540.360.430.450.12
Beta‐CoV pangolin0.390.240.360.28570.390.400.220.08
SARS CoV0.360.290.310.23600.430.460.410.12
Bat SARS CoV0.390.280.300.22570.410.440.430.12
MERS CoV0.430.270.280.19600.380.430.450.12
NucleocapsidSARS‐CoV‐20.400.290.380.16530.360.47−0.970.07
Beta‐CoV pangolin0.410.290.380.15540.350.47−0.990.07
SARS CoV0.380.310.390.15540.370.48−1.020.07
Bat SARS CoV0.390.300.390.16550.370.48−1.000.07
MERS CoV0.450.290.310.17500.370.48−0.870.07

Abbreviations: CoV, coronavirus; MERS, Middle East respiratory syndrome; SARS, severe acute respiratory syndrome.

The codon usage indices of S, E, M, and N genes SARS‐CoV‐2, pangolins Beta‐CoV, SARS CoV, Bat CoV, and MERS CoV Abbreviations: CoV, coronavirus; MERS, Middle East respiratory syndrome; SARS, severe acute respiratory syndrome. In the E gene, T nucleotides were the most predominant (34.5%‐40.4%) followed by A (21.5%‐25.7%). SARS‐CoV‐2 showed the lowest GC% (38.2%) and the highest AT% (63%), compared with bat SARS, MERS, and SARS CoV. In addition, SARS‐CoV‐2 has the lowest frequency of G/C nucleotides. In all of the examined dCoVs, the nucleotide percentages in the E gene were in the following order: T>A>C>G. In NT3s, the T3s and G3s were the most and the least frequent nucleotides, respectively. In the N gene, A nucleotides were the most predominant (29.6%‐31.7%) followed by C (25%‐29%). There was little or no differences in GC% and AT% between the CoVs with a conserved tendency for higher AT%. The nucleotide percentages in the N gene were in the following order: A>C>G>T for SARS‐CoV‐2, SARS, and bat SARS CoVs, while MERS CoV showed a revised order of A>C>T>G. In NT3s, the T3s and G3s were the most and the least frequent nucleotides, respectively. In the M gene, T nucleotides were the most predominant (29.9%‐31.9%) followed by A (24.4%‐25.6%). SARS‐CoV‐2 showed the lowest GC% (42.6%) and the highest AT% (57.4%), compared with bat SARS, MERS, and SARS CoV. In addition, SARS‐CoV‐2 and pangolins Beta‐CoV showed slightly lower G/C nucleotides at the third position of codons. In all of the examined CoVs, the nucleotide percentages in the M gene were in the following order: T>A>C>G. In NT3s, similar to other structural genes, the T3s and G3s were the most and the least frequent nucleotides, respectively. In RdRP, T and A nucleotides were the most predominant nucleotides. In addition, SARS‐CoV‐2 showed the highest T3s and the lowest G3s (Table 2). In contrast, pangolins Beta‐CoV and MERS CoV showed the lowest A3s and the highest G3s frequencies. Therefore, similar to structural genes, RdRP contained pyrimidine nucleotides more frequent than purines. For Mpro, there is a conserved profile of general preference for T3s and low frequencies for G3s. Both SARS‐CoV‐2 and pangolin Beta‐CoV showed the lowest G3s frequencies.
Table 2

The codon usage indices of RdRP and Mpro genes SARS‐CoV‐2, pangolins Beta‐CoV, SARS CoV, Bat CoV, and MERS CoV

VirusT3sC3sA3sG3sNcGC3sGCGravyAromo
RdRPSARS‐CoV‐20.420.250.390.2050.910.350.390.020.14
Beta‐CoV pangolin0.380.230.390.2751.810.390.390.240.11
SARS CoV0.400.250.360.2453.320.380.420.100.11
Bat SARS CoV0.410.220.360.2552.230.370.410.200.09
MERS CoV0.380.250.330.2755.570.410.430.370.11
MproSARS‐CoV‐20.520.210.420.1345.680.270.37−0.230.13
Beta‐CoV pangolin0.540.200.400.1346.650.260.37−0.210.13
SARS CoV0.510.220.370.1848.910.310.39−0.200.13
Bat SARS CoV0.490.240.370.1950.230.320.40−0.200.13
MERS CoV0.540.250.280.2150.950.350.40−0.180.14

Abbreviations: CoV, coronavirus; Mpro, main protease; MERS, Middle East respiratory syndrome; RdRP, RNA‐dependent RNA polymerase; SARS, severe acute respiratory syndrome.

The codon usage indices of RdRP and Mpro genes SARS‐CoV‐2, pangolins Beta‐CoV, SARS CoV, Bat CoV, and MERS CoV Abbreviations: CoV, coronavirus; Mpro, main protease; MERS, Middle East respiratory syndrome; RdRP, RNA‐dependent RNA polymerase; SARS, severe acute respiratory syndrome.

RSCU analysis

In Tables 3, 4, and Table S1, the RSCU values for codons of CoV structural and nonstructural genes are provided, respectively. The tables are colored by a color scheme to denote the levels of codon usage bias. A value of RSCU =1 means that the observed frequency of codon is equivalent to the predictable frequency and indicating the lack of any codon usage bias. The underrepresented or negatively biased codons denote RSCU <0.6 (blue color), the overexpressed or positively biased codons with RSCU >0.6 (red color). The range between 0.6 and 1.6 conforms to the nonbiased codons.
Table 3

RSCU values of structural genes (S and E) from SARS‐CoV‐2, pangolins Beta‐CoV, SARS CoV, Bat CoV, and MERS CoV

Abbreviations: CoV, coronavirus; MERS, Middle East respiratory syndrome; RSCU, relative synonymous codons usage; SARS, severe acute respiratory syndrome.

Table 4

RSCU values of structural genes (M and N genes) from SARS‐CoV‐2, pangolins Beta‐CoV, SARS CoV, Bat CoV, and MERS CoV

Abbreviations: CoV, coronavirus; MERS, Middle East respiratory syndrome; RSCU, relative synonymous codons usage; SARS, severe acute respiratory syndrome.

RSCU values of structural genes (S and E) from SARS‐CoV‐2, pangolins Beta‐CoV, SARS CoV, Bat CoV, and MERS CoV Abbreviations: CoV, coronavirus; MERS, Middle East respiratory syndrome; RSCU, relative synonymous codons usage; SARS, severe acute respiratory syndrome. RSCU values of structural genes (M and N genes) from SARS‐CoV‐2, pangolins Beta‐CoV, SARS CoV, Bat CoV, and MERS CoV Abbreviations: CoV, coronavirus; MERS, Middle East respiratory syndrome; RSCU, relative synonymous codons usage; SARS, severe acute respiratory syndrome. In the S gene, the over‐biased codons, SARS‐CoV‐2 showed the highest number of over‐biased codons (10 codons), including CTT, ATT, GTT, TCT, CCT, CCA, ACT, GCT, AGA, and GGT. All of these codons contained A3s or T3s. In contrast, pangolin Beta‐CoV, SARS CoV, bat SARS CoV, and MERS CoV showed 8, 8, 9, and 8 over‐biased codons, respectively (Table 3). Therefore, SARS‐CoV‐2 has the largest number of over‐biased codons. The over‐biased codons were similar to that provided for SARS‐CoV‐2 except for CCA and ACT for pangolin Beta‐CoV, CCA, and GGT for SARS CoV, CCA for bat SARS CoV and ATT and CCA for MERS CoV. In the N gene, the over‐biased codons, SARS‐CoV‐2 showed the highest number of over‐biased codons (six codons), including TTG, CTT, ATT, ACT, GCT, and AGA. In contrast, pangolin Beta‐CoV, SARS CoV, bat SARS CoV, and MERS CoV showed 4, 4, 4, and 5 over‐biased codons, respectively (Table 4). Therefore, SARS‐CoV‐2 has the largest number of over‐biased codons in the N gene. The over‐biased codons were similar to that provided for SARS‐CoV‐2 except TTG for pangolin Beta‐CoV, TTG, and CTT for SARS TTG and CTT for bat SARS CoV and TTG for MERS CoV. For MERS CoV, the over‐biased codons were slightly different and included CTT, ATT, TCT ACT, GCT, TAC, and AGA. In the M gene, the over‐biased codons were CTT, ATT, GTA, GCT, CCA, GAC, GAA, TGT, CGT, and GGA for SARS‐CoV‐2 (10 codons), CTT, ATT, TCT, TCA, GCT, CCA, and GGA for pangolin Beta‐CoV (seven codons), CTT, ATT, GTA, GCT, CCA, GAC, TGT, and CGT for SARS CoV and bat SARS CoV (eight codons), CTT, ATT, GTA, GCT, CCA, GAC, TGT, GGT, and CGT for MERS CoV (nine codons). GGA and GAA codons were nonbiased codons in all coronaviruses except for the SARS‐CoV‐2 and pangolin Beta‐CoV were over‐biased. In the E gene, the codon usage could be biased by the short length of the E gene that favors excluding its delivered RSCU values. The frequent negatively biased codons among CoVs include CTG, TCG, AGC, CCG, ACC, ACG, GCG, CGC, and GGG in the S gene, ATA, GTA, TGC, GCG, TGT, AGG and TGC in the N gene and ATA, TGC, and CCC in the M gene. The number of over‐biased and negatively biased codons were compared in SARS‐CoV‐2, pangolin Beta‐CoV, SARS CoV, Bat CoV, and MERS CoV. SARS‐CoV‐2 almost coding the highest number of over‐biased and negatively biased codons among all of the structural proteins. In the S gene, SARS‐CoV‐2 bears 12 and 19 over‐biased and negatively biased codons, respectively. The SARS‐CoV‐2/SARS over‐biased codons ratio was 1.2, 1.14, and 1.44 for S, N, and M genes, respectively. In addition, The SARS‐CoV‐2/SARS negatively biased codons ratio was 1, 1.2, and 1.44 for S, N, and M genes, respectively. Therefore, the SARS‐CoV‐2 showed the highest number of extreme codon usage patterns of over‐ or under‐biased codons, followed by SARS CoV. The gap between SARS‐CoV‐2 and SARS CoVs is more tighter than the gap of SARS‐CoV‐2 or SARS CoV and the bat SARS CoV, which showed a much lower number of biased codons in comparison with the other viruses. MERS CoV showed a higher number of biased codons only in the N gene, compared with SARS and SARS‐CoV‐2. The structural genes undertook a homogenous profile of codon usage with little differences among the genes. In contrast, NSP as RdRP and Mpro showed larger variations. RdRP showed three over‐biased codons and eight common under‐biased codons. SARS‐CoV‐2 and pangolin Beta‐CoV showed the highest number of under‐biased codons (12 codons). Compared to 10 codons in SARS and bat SARS and five codons in MERS CoV (Table S1). In Mpro, the number of over‐ and under‐biased genes were 11, 10, 8, 8, 6 and 15, 15, 14, 11, and 9 for SARS‐CoV‐2, pangolin Beta‐CoV, SARS, bat SARS, and MERS CoVs, respectively. This agrees with the general predicted highest number of biased codons in SARS‐CoV‐2.

Effective number of codons

ENc implies the effective number of codons and can be used as a measure of codon usage bias. ENc values range from 20 to 61. As the ENc value increases, the codon usage bias is lower. Low ENc value indicates high codon usage bias. SARS‐CoV‐2 showed the lowest ENc value for all nonstructural and structural genes, compared with pangolins Beta‐CoV, SARS, and bat SARS CoVs (Figure 1). MERS CoV has the lowest ENc value for N and RdRP. The differences between ENc values between SARS‐CoV‐2 and pangolins Beta‐CoV were 0.6, 4.2, 2.9, 0.7, and 0.7 for S, E, M, N, RdRP, and Mpro. These values were the lowest differences compared with the other CoVs.
Figure 1

Effective number of codons values for structural (S, E, M, N) and nonstructural genes (RNA‐dependent RNA polymerase and main protease genes) from SARS‐CoV‐2, pangolins Beta‐CoV, SARS CoV, Bat CoV, and MERS CoV. CoV, coronavirus; MERS, Middle East respiratory syndrome; SARS, severe acute respiratory syndrome

Effective number of codons values for structural (S, E, M, N) and nonstructural genes (RNA‐dependent RNA polymerase and main protease genes) from SARS‐CoV‐2, pangolins Beta‐CoV, SARS CoV, Bat CoV, and MERS CoV. CoV, coronavirus; MERS, Middle East respiratory syndrome; SARS, severe acute respiratory syndrome

DISCUSSION

Codon usage bias is used in the analysis of genes composition and conclusion of the forces controlling evolution and functions. , It has been used in the analysis of viral structural , and nonstructural genes. , In this study, the codon usage bias and genomic composition were compared in structural proteins of the three major CoV epidemics—SARS, MERS, and SARS‐CoV‐2. In correlation with the previous knowledge of CoVs genome composition, AT% was higher than GC% in SARS‐CoV‐2. , In all of the structural genes of SARS‐CoV‐2, either A or T nucleotides were the most predominant nucleotides. In addition, A or T nucleotides were the most predominant nucleotides at the 3rd position of codons. This is in agreement with the previous studies of CoVs. , RNA viruses had evolved high ENc value (>35), implying low codon bias to adapt a wide range of hosts with various codon usage preferences. ENc values above 50, in general, mean low codon usage bias. The codon usage data indicated lower number of ENc values of the SARS‐CoV‐2 compared with SARS, bat SARS, and pangolin CoV. This indicates a higher codon usage bias of SARS‐CoV‐2. Within these CoVs, pangolin CoV had the least ENc differences. There is a negative correlation between the ENc value and codon usage bias. ENc values indicate higher codon usage bias in SARS‐CoV‐2 compared with SARS and MERS CoVs, due to lower ENc values, which is mostly observed in S, E, and M genes and to a lesser extent in N and RdRP genes. In SARS, bat SARS, and MERS CoVs E gene, ENc was >60, while in SARS‐CoV‐2, the ENc value was decreased by an amount of 18 to be no more than 42. Similarly, the M gene ENc value in SARS‐CoV‐2 was decreased by an amount of 3 to 5. Genes with low expression levels have high ENc values and more rare codons. The expression of highly biased genes is considered as high. The relative expression can be concluded from the ENc value, where small ENc value indicates higher bias and a generally higher level of expression. Thus, the small ENc value is suggesting for higher gene expression. The lower observed ENc, especially for Spike and Envelope genes, values for SARS‐CoV‐2 structural genes are indicative for higher gene expression potency. Supporting information Click here for additional data file. Supporting information Click here for additional data file. Supporting information Click here for additional data file. Supporting information Click here for additional data file. Supporting information Click here for additional data file. Supporting information Click here for additional data file. Supporting information Click here for additional data file.
  29 in total

1.  Codon usage tabulated from international DNA sequence databases: status for the year 2000.

Authors:  Y Nakamura; T Gojobori; T Ikemura
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  The Code of Silence: Widespread Associations Between Synonymous Codon Biases and Gene Function.

Authors:  Fran Supek
Journal:  J Mol Evol       Date:  2015-11-04       Impact factor: 2.395

3.  The transmissible gastroenteritis coronavirus contains a spherical core shell consisting of M and N proteins.

Authors:  C Risco; I M Antón; L Enjuanes; J L Carrascosa
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

Review 4.  Roles for Synonymous Codon Usage in Protein Biogenesis.

Authors:  Julie L Chaney; Patricia L Clark
Journal:  Annu Rev Biophys       Date:  2015-02-26       Impact factor: 12.981

5.  Constraints of Viral RNA Synthesis on Codon Usage of Negative-Strand RNA Virus.

Authors:  Ryan H Gumpper; Weike Li; Ming Luo
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

6.  Synonymous and Biased Codon Usage by MERS CoV Papain-Like and 3CL-Proteases.

Authors:  Mahmoud Kandeel; Abdallah Altaher
Journal:  Biol Pharm Bull       Date:  2017-04-18       Impact factor: 2.233

7.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.

Authors:  Roujian Lu; Xiang Zhao; Juan Li; Peihua Niu; Bo Yang; Honglong Wu; Wenling Wang; Hao Song; Baoying Huang; Na Zhu; Yuhai Bi; Xuejun Ma; Faxian Zhan; Liang Wang; Tao Hu; Hong Zhou; Zhenhong Hu; Weimin Zhou; Li Zhao; Jing Chen; Yao Meng; Ji Wang; Yang Lin; Jianying Yuan; Zhihao Xie; Jinmin Ma; William J Liu; Dayan Wang; Wenbo Xu; Edward C Holmes; George F Gao; Guizhen Wu; Weijun Chen; Weifeng Shi; Wenjie Tan
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

8.  The COVID-19 epidemic.

Authors:  Thirumalaisamy P Velavan; Christian G Meyer
Journal:  Trop Med Int Health       Date:  2020-02-16       Impact factor: 2.622

9.  Analysis of preferred codon usage in the coronavirus N genes and their implications for genome evolution and vaccine design.

Authors:  Abdullah Sheikh; Abdulla Al-Taher; Mohammed Al-Nazawi; Abdullah I Al-Mubarak; Mahmoud Kandeel
Journal:  J Virol Methods       Date:  2020-01-05       Impact factor: 2.014

10.  Analysis of synonymous codon usage in SARS Coronavirus and other viruses in the Nidovirales.

Authors:  Wanjun Gu; Tong Zhou; Jianmin Ma; Xiao Sun; Zuhong Lu
Journal:  Virus Res       Date:  2004-05       Impact factor: 3.303

View more
  62 in total

1.  Codon Usage of Hepatitis E Viruses: A Comprehensive Analysis.

Authors:  Bingzhe Li; Han Wu; Ziping Miao; Linjie Hu; Lu Zhou; Yihan Lu
Journal:  Front Microbiol       Date:  2022-06-21       Impact factor: 6.064

2.  Natural selection plays a significant role in governing the codon usage bias in the novel SARS-CoV-2 variants of concern (VOC).

Authors:  Neetu Tyagi; Rahila Sardar; Dinesh Gupta
Journal:  PeerJ       Date:  2022-06-23       Impact factor: 3.061

3.  Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays.

Authors:  Jingyou Yu; Zhenfeng Li; Xuan He; Makda S Gebre; Esther A Bondzie; Huahua Wan; Catherine Jacob-Dolan; David R Martinez; Joseph P Nkolola; Ralph S Baric; Dan H Barouch
Journal:  J Virol       Date:  2021-03-16       Impact factor: 6.549

4.  The Evolution of Severe Acute Respiratory Syndrome Coronavirus-2 during Pandemic and Adaptation to the Host.

Authors:  Snawar Hussain; Sahibzada Tasleem Rasool; Shinu Pottathil
Journal:  J Mol Evol       Date:  2021-05-15       Impact factor: 3.973

Review 5.  The Mechanisms and Animal Models of SARS-CoV-2 Infection.

Authors:  Wenrui Jia; Juan Wang; Bao Sun; Jiecan Zhou; Yamin Shi; Zheng Zhou
Journal:  Front Cell Dev Biol       Date:  2021-04-27

6.  Relative synonymous codon usage of ORF1ab in SARS-CoV-2 and SARS-CoV.

Authors:  Gun Li; Liang Zhang; Ning Du
Journal:  Genes Genomics       Date:  2021-07-06       Impact factor: 1.839

Review 7.  Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection.

Authors:  K A Dvornikova; E Yu Bystrova; L P Churilov; A Lerner
Journal:  Mol Biol Rep       Date:  2021-07-22       Impact factor: 2.742

8.  Mutational Asymmetries in the SARS-CoV-2 Genome May Lead to Increased Hydrophobicity of Virus Proteins.

Authors:  Roman Matyášek; Kateřina Řehůřková; Kristýna Berta Marošiová; Aleš Kovařík
Journal:  Genes (Basel)       Date:  2021-05-27       Impact factor: 4.096

Review 9.  Environmental impacts of coronavirus disease 2019 (COVID-19).

Authors:  Veer Singh; Vishal Mishra
Journal:  Bioresour Technol Rep       Date:  2021-06-25

10.  Genetic Control of Human Infection with SARS-CoV-2.

Authors:  A N Kucher; N P Babushkina; A A Sleptcov; M S Nazarenko
Journal:  Russ J Genet       Date:  2021-07-03       Impact factor: 0.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.